Global Commercial Director - Immunology

At AstraZeneca, we are driven by a bold ambition: to deliver life-changing medicines that help achieve clinical remission in immune-mediated diseases. We have already made significant progress through the launch of a leading biologic treatment for systemic lupus erythematosus (SLE), the recent launch of a subcutaneous formulation has expanded this further. With four further Phase 3 development programs currently ongoing in Cutaneous Lupus (CLE), Systemic Sclerosis (SSc), Lupus Nephritis (LN) an…

Summary and match are AI-generated; verify details on the original posting.

Listed via Adzuna. All sources